STOCK TITAN

ProQR Therapeutics N.V. (PRQR) EPS by Year

PRQR

ProQR Therapeutics N.V. lost $0.47 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters ProQR Therapeutics N.V. has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.47
YoY n/m
5Y CAGR n/m
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

PRQR EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-F
EPS (Diluted)-$0.47n/m-$0.33n/m-$0.39n/m-$0.96n/m-$1.08n/m-$1.14n/m-$1.55N/AN/AN/AN/A

PRQR EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ3'256-KQ2'256-KQ1'256-KQ4'2420-FQ3'246-KQ2'246-KQ1'246-KQ4'2320-FQ3'236-KQ2'236-KQ1'236-K
EPS (Diluted)-$0.09n/m-$0.12n/m-$0.14n/m-$0.11n/m-$0.09n/m-$0.11n/m-$0.03n/m-$0.10n/m-$0.08n/m-$0.07n/m-$0.11n/m-$0.12n/m

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More ProQR Therapeutics N.V. financials

Frequently Asked Questions

What was ProQR Therapeutics N.V.'s diluted earnings per share in fiscal year 2025?

ProQR Therapeutics N.V. lost $0.47 per diluted share in fiscal year 2025.

How fast is ProQR Therapeutics N.V.'s diluted earnings per share growing?

ProQR Therapeutics N.V. (PRQR) reported a loss of $0.33 per diluted share in fiscal year 2024 and a loss of $0.47 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

What was ProQR Therapeutics N.V.'s diluted earnings per share in the most recent quarter?

ProQR Therapeutics N.V. (PRQR) reported -$0.09 in diluted earnings per share in Q4 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what ProQR Therapeutics N.V. (PRQR) reported on that line in every period on record.